Recent studies have identified that Alzheimer’s disease (AD)-related risk genes, such as WW domain-containing oxidoreductase (WWOX) and MAF bZIP transcription factor (MAF), significantly affect language, memory, and executive function in PD patients, suggesting overlapping molecular mechanisms between AD and PD in cognitive dysfunction (Yuan et al., 2025). This evidence concerns the gene MAF and Alzheimer disease.